Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
Phase 2
52
about 5.5 years
55+
1 site in MD
What this study is about
Researchers are testing if a medication called CORT108297 can help reduce the negative effects of stress on memory. The trial will involve people with mild cognitive impairment due to Alzheimer's disease and those at risk for developing Alzheimer's, who will receive either CORT108297 or a placebo over 10 weeks. Researchers will measure their cognitive performance before and after treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take CORT108297
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Neurology